Plant vs Animal-based Protein Sources as an Anabolic and Metabolic-protective Options for SO in Older Adults
Plant (Legumes) vs Animal-based (Meat) Protein Sources as an Anabolic and Metabolic-protective Options for Sarcopenic Obesity in Older Adults- A Randomized Controlled Trial
1 other identifier
interventional
180
1 country
1
Brief Summary
This study is testing how different types of protein - from red meat, legumes (like lentils and beans), or a mix of both - affect muscle strength, body composition, and metabolic health in older adults with obesity who are also at risk for sarcopenia (loss of muscle mass and function). Participants will follow a personalized weight loss diet with one high-protein meal each day that includes either red meat, legumes, or both, along with a home-based strength training program. The study will last three months and will include health assessments such as blood tests, muscle and fat measurements, and physical function tests. The goal is to find out which type of protein source is most helpful for improving strength, reducing body fat, and supporting healthy aging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2025
CompletedFirst Posted
Study publicly available on registry
June 22, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedJune 22, 2025
May 1, 2025
6 months
June 12, 2025
June 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MetaboAnabolic Score
The MetaboAnabolic Score is a composite outcome designed to assess the intervention's efficacy in addressing sarcopenic obesity from both metabolic and functional perspectives. The score includes 10 variables: five metabolic (body fat percentage, intramuscular adipose tissue \[IMAT\], visceral fat area, blood pressure, and triglyceride or LDL levels) and five functional (leg muscle/lean mass, leg and arm strength, Timed Up and Go \[TUG\], and 2-minute walk test). A clinically meaningful threshold is defined for each variable based on scientific literature or expected changes from the hypocaloric intervention. One point is awarded for each variable that meets or exceeds the threshold, resulting in a total score ranging from 0 to 10. A higher score reflects greater overall improvement.
Baseline, Week 6, Week 12
Secondary Outcomes (10)
Functional Performance Tests (TUG, STS, Gait, Strength)
Baseline, Week 6, Week 12
C-Reactive Protein (CRP) Levels
Baseline, Week 6, Week 12
Lipid Profile (Triglycerides, LDL, HDL, Total Cholesterol)
Baseline, Week 6, Week 12
Glycemic Control (Fasting Glucose, Insulin, HOMA-IR)
Baseline, Week 6, Week 12
Resting Metabolic Rate (RMR)
Baseline and Week 12
- +5 more secondary outcomes
Other Outcomes (1)
Banked Blood and Serum for Future Biomarker and Epigenetic Analysis
Baseline, Week 6, Week 12
Study Arms (3)
ProLegumes Diet
EXPERIMENTALParticipants in this arm will follow a hypocaloric, high-protein diet primarily based on legumes as the main protein source. The diet aims to improve sarcopenic obesity outcomes over a 3-month intervention period, combined with home-based resistance training.
ProMeat Diet
ACTIVE COMPARATORParticipants in this arm will follow a hypocaloric, high-protein diet primarily based on meat as the main protein source. This diet also aims to improve sarcopenic obesity outcomes over 3 months with the same exercise regimen.
ProMix Diet
ACTIVE COMPARATORParticipants in this arm will follow a hypocaloric, high-protein diet that includes a combination of both legumes and meat as protein sources. The intervention period and exercise program are identical to the other arms.
Interventions
Participants receive a hypocaloric, high-protein diet primarily based on legumes (e.g., lentils, beans, peas) designed to meet protein goals (\~2g/kg body weight). Diet is combined with a structured home-based resistance training program performed 3 times per week for 12 weeks. The exercise includes progressive resistance exercises focusing on major muscle groups using body weight and resistance bands.
Participants follow a hypocaloric, high-protein diet emphasizing animal-based protein sources, mainly lean meats, to achieve \~2g/kg body weight protein intake. This dietary intervention is combined with a 12-week, home-based resistance training protocol, performed thrice weekly, targeting major muscle groups with progressive overload using body weight and resistance bands.
Participants adhere to a hypocaloric, high-protein diet combining both legumes and lean meats as protein sources to reach \~2g/kg body weight. The dietary plan is paired with a 12-week home-based resistance training program, performed 3 times per week, emphasizing progressive resistance exercises for all major muscle groups using body weight and resistance bands.
Eligibility Criteria
You may qualify if:
- Aged 55 years or older.
- Diagnosed with obesity.
- At risk for sarcopenia, based on at least one of the following: Low score on the validated SARC-F-calf questionnaire (as suggested in prior studies). More than one comorbidity associated with sarcopenic obesity (e.g., diabetes, osteoporosis, cardiovascular disease, etc.). Polypharmacy: taking 8 or more prescribed medications. Evidence of strength or functional impairment, assessed using validated measurements at the baseline visit.
You may not qualify if:
- Recent use of steroid agents within the past 6 months (replacement therapy is allowed).
- Uncorrected hypothyroidism: TSH \> 6 mIU/L.
- Diagnosis of malignancy within the past 5 years, except for non-melanoma skin cancer.
- Chronic kidney disease (CKD) at stage \>1 (due to protein restriction needs).
- Recent (≤6 months) or unstable cardiovascular condition, or NYHA Class III or higher congestive heart failure.
- Currently performing resistance training.
- Currently undergoing nutritional therapy, have recently changed diet (\<1 month), or are enrolled in active weight-loss programs or therapies (including lifestyle and/or pharmacotherapy). Note: Patients stable on GLP-1 agonists or other pharmacotherapy are eligible.
- Vegetarians/vegans, or individuals with aversion or allergy to all legumes or all red meat products.
- Habitual consumption of more than 3 servings/week of either legumes or red meat.
- Other medical, psychiatric conditions, or lab abnormalities that may pose a risk to participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tel Aviv Sourasky Medical Center
Tel Aviv, Tel Aviv, 6423906, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Investigators, physical trainers, and outcomes assessors are blinded to group allocation. Participants and dietitians delivering the dietary intervention are not blinded, due to the nature of individualized nutrition counseling. All meals are coded neutrally to preserve blinding for trainers and assessors.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 12, 2025
First Posted
June 22, 2025
Study Start
September 1, 2025
Primary Completion
March 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
June 22, 2025
Record last verified: 2025-05